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Background
Air pollution is a growing concern in developing countries 
contributing to >620 000 deaths among Indians annually.1 As 
per recent estimates from Global Burden of Disease (GBD), 
2017, 10.6% of total deaths, 6.4% of total disability-adjusted 
life years, and 30% of cardiovascular deaths in India are attrib-
utable to ambient PM2.5 exposures.2 The annual population-
weighted mean exposure to ambient particulate matter PM2.5 
in India was 89.9 µg/m3 (95% confidence interval [CI]: 67.0-
112.0) in 2017,1 far exceeding the World Health Organization 
(WHO) target of 10 µg/m3.3 Due to the limited spatial cover-
age of ground-level monitoring stations, there has been an 
increasing interest in the use of alternative methods to predict 
air pollution exposures in India.
The majority of evidence of health effects of air pollution 
has come from developed countries which does not account for 
the complex rapid urbanization happening in developing coun-
tries. Moreover, the composition of air pollution is very differ-
ent in low- and middle-income countries (LMICs), and the 
health impact is influenced by several other meteorological, 
demographic, and built environment factors. The health 
impacts of air pollution are myriad and include respiratory and 
cardiometabolic diseases to reproductive disorders and infant 
morbidity.4 After respiratory disorders, cardiometabolic dis-
orders are the most important diseases that are attributable 
to exposure to ambient air pollution,5 specifically PM2.5.6 
Prospective cohort studies are very useful for studying multiple 
outcomes and are among the strongest designs for evaluating 
causal effects outside of randomized controlled trials. While 
several cohort studies exist in India, they have largely focused 
on pregnancy and birth outcomes. There are very few well-
phenotyped adult cohorts focused on cardiometabolic health 
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that are now beginning to study the impact of environmental 
risk factors on chronic diseases.
Considering that India is home to one-fifth of the world’s 
population, studies specific to the Indian scenario are urgently 
needed to shift policy discourse around ambient air pollution. 
Findings from a large multicountry study reported that stroke 
and ischemic heart disease (IHD) were 2 largest contributors 
for premature deaths and accounted for 74% of the total pre-
mature deaths in South and South-East Asia,7 with India con-
tributing the most premature deaths of any country in the 
region. To date, only 1 study has evaluated the impact of air 
pollution on cardiometabolic disease outcomes in India: a 
time-series study in Varanasi that found that the achievement 
of the WHO air quality standard would prevent 1900 prema-
ture deaths every year.8 With improved air quality, modeled 
data estimates indicate that 24.0% of IHD and 18.5% of stroke 
deaths in India could be averted.9
The overall goal of the present GEOHealth (Global 
Environmental and Occupational Health) India Hub program 
is to leverage an ongoing cohort study in India, the Centre for 
cArdiometabolic Risk Reduction in South-Asia (CARRS) 
surveillance study,10 to evaluate the prospective effects of 
ambient air pollution on cardiometabolic health outcomes and 
associated traits. The study also leverages publicly available 
information on air quality, meteorological variables, and other 
environmental factors (like land use and emission inventories) 
for the analysis of complex spatiotemporal data and multipol-
lutant exposures, and can serve as a proof of concept for other 
ongoing cohort studies in India and around the world. The 
analysis is facilitated by previously developed and validated 
prediction models for PM2.5 in the United States that combine 
land-use regression (LUR) with satellite-derived aerosol opti-
cal depth (AOD) data to estimate particle exposure.11
In addition, we are building on existing laboratory capacity in 
India to explore factors that may mediate the association between 
air pollution and cardiometabolic disease such as DNA methyla-
tion and vitamin D levels. Methylomics provides a unique 
opportunity to reconstruct past exposures, particularly those 
such as air pollution and other exposures that augment oxidative 
stress, to which the methylome is exquisitely sensitive.12 Air pol-
lution in particular is known to alter DNA methylation that in 
turn is known to be associated with cardiometabolic health 
outcomes.13-15 Similarly, there is strong evidence on effect of 
Vitamin D levels and deficiency with various cardiometabolic 
outcomes.16-21 Particulate air pollution reduces effective UV-B 
exposure, which is critical for producing the biologically active 
form of vitamin D, and contributes to variation in the UV index, 
along with other factors such as latitude, season, skin pigmenta-
tion, and the use of sun-protective wear.22,23
Similar to this context, the GBD estimates emerge from a 
low-resolution chemical transport model that estimates partic-
ulate matter levels with considerable error and exposure-
response functions based largely on research from low- and 
mid-level exposure settings.24 Most of the air pollution studies 
in LMICs (largely represented by China) are time-series/eco-
logical study design with a short observation period which often 
has no spatiotemporal resolution of pollution parameters and 
focuses only on short-term health outcomes.25 Hence, this 
research will provide crucial, country-specific evidence of the 
health effects of air pollution to provide evidence for appropri-
ate policy reforms. This study will also demonstrate how exist-
ing cohorts with longitudinal information on cardiometabolic 
health can be used to understand emerging risk factors and pro-
vide timely scientific data to inform cardiometabolic disease 
prevention and air pollution mitigation policies.
CARRS Cohort
The CARRS surveillance study is a hybrid cohort-modeled 
cross-sectional study involving a baseline survey followed by 
repeat surveys carried out in subsequent years with a response 
rate of approximately 85%. The CARRS participants were 
recruited at baseline in 2010-2012 (Cohort 1) from 3 urban 
sites, Delhi and Chennai in India and Karachi in Pakistan. 
Thereafter, more participants were recruited from these cities 
in 2014-2016 (Cohort 2) to achieve larger sample size to 
understand the incidence of cardiometabolic risk factors, dis-
eases, comorbidities, and mortality10 in this south-east Asian 
region.
Households were selected in each of the 3 cities using a 
multistage cluster random sampling technique from each ward 
and census enumeration blocks. Two participants, 1 male and 1 
female, aged 20 years or older and permanently residing in the 
household, were selected from each household using “Kish 
method” used in the WHO’s (World Health Organisation 
stepwise Approach to Surveillance) (STEPS) surveys. Pregnant 
women and bed-ridden individuals were excluded from the 
study, and information on basic demographic details of these 
excluded individuals was recorded along with non-participat-
ing eligible participants. To provide consistency and reproduc-
ibility of the results across multiple sites and across different 
follow-ups, comprehensive and uniform data collection instru-
ments were used to capture measurements. The details of all 
the data collection and study procedures have been described 
previously.10
The CARRS participants (Table 1) were phenotyped for a 
range of cardiovascular diesease (CVD) risk factors at baseline. 
Thereafter, every year these participants are being followed for 
CVD events and additionally for lifestyle factors, physical 
examinations, and biological samples as well in every alternate 
year (Table 2). This intense phenotype and built environment 
data are integrated into a Geographical Information System 
(GIS)–linked database. The data on geocoded residence of the 
participants and how long they have lived at their present loca-
tion provide an excellent opportunity to estimate air pollution 
exposure levels. As far as possible, we are also trying to gather 
information on migration and also geocode current residence 
of the participants, if they have migrated within the cities. 
Written informed consent was obtained from CARRS 
Walia et al 3
participants to utilize their de-identified phenotype data and 
stored de-identified biological samples for future cardiovascu-
lar research.
The GEOHealth program is utilizing information from the 
Delhi and Chennai sites having a very different cardiometa-
bolic profile along with different geospatial determinants and 
air pollution levels and composition. We are restricting our 
GEOHealth proposed objectives to only Indian cities for 
logistic and feasibility purposes around estimating ambient air 
pollution exposure levels.
Research Aims
Aim 1: Estimate air pollution exposure in Chennai 
and Delhi at f ine spatiotemporal resolution
We will develop and validate exposure models to estimate daily 
exposure to fine particulate matter (PM2.5) at a 1 km × 1 km spa-
tial resolution from 2010 to 2016.26 The predicted concentrations 
will be used to assign ambient air pollution exposure values to 
>15 000 CARRS households in Chennai and New Delhi. The 
prediction models are based on machine learning methodologies 
Table 1. Baseline Characteristics of CARRS cohort.
VARIABLES CATEGORIES CARRS-I CARRS-II
CHENNAI DELHI TOTAL CHENNAI DELHI TOTAL
N 6906 5364 12 270 4866 4725 9591
Age, mean (SD) 41.4 (12.7) 44.4 (13.5) 42.9 (13.1) 43.6 (13.1) 45.0 (13.8) 44.3 (13.4)
Gender
 Male 3188 2680 5868 2247 2243 4490
 Female 3718 2684 6402 2619 2482 5101
Occupation
 Not working 3502 2754 6256 2296 2717 5013
 Semi-/unskilled 1757 971 2728 1333 661 1994
 Trained/skilled 1539 1342 2881 1160 1247 2407
 White collar 108 297 405 77 100 177
Abbreviations: CARRS, Centre for cArdiometabolic Risk Reduction in South-Asia; SD, standard deviation.
Table 2. Summary of data collected over time in CARRS cohort study.
COHORT N AVAILABLE DATAa
CARRS-I
 Baseline (2010-2012) 12 271  • Sociodemographic indicatorsb
 • Socioeconomic statusb
 • Health expenditure
 • Lifestyle risk factors such as tobacco and alcohol use, diet, and 
physical activity
 • Body fat distribution (anthropometry and bioelectric impedance)
 • Self-reported and incident hypertension, diabetes, stroke, MI, other 
cardiovascular diseases (CVD), CKDc
 • Serological and biochemical parameters such as lipids and 
glycemic traits, LFT, KFT, inflammatory markers, cotinine levels
 • ECG data (only for Delhi site)d
 • Biorepository for future studies (DNA, serum, plasma, urine, buffy 
coats, etc)
 1st FUP (2011-2013) 9194
 2nd FUP (2013-2014) 9619
 3rd FUP (2014) 8115
 4th FUP (2016-2017) 7372
 5th FUP (2017-2018) 6969
CARRS-II
 Baseline (2014-2016) 9594
 1st FUP (2018-2020) Ongoing
Abbreviations: CARRS, Centre for cArdiometabolic Risk Reduction in South-Asia; CVD, cardiovascular disease; CKD, chronic kidney disease; ECG, electrocardiogram; 
FUP, follow-up; KFT, kidney function test; LFT, liver function test; MI, myocardial infarction
aThe detailed phenotyping including CVD risk factors, physical measures, and biological samples was taken at baseline and 2nd and 4th follow-ups. Events and cause of 
death data were captured only in 1st, 3rd, and 5th follow-ups.
bAvailable for baseline and 4th follow-up.
cEvents and cause of death available at all time points.
dAvailable at 2nd and 4th follow-ups.
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and ensemble averaging while using ground monitoring data, sat-
ellite measurements, meteorological data, land-use variables, and 
emission inventories.11 The major advantage of this modeling 
exercise is that it enables us to obtain neighborhood-level ambi-
ent concentrations irrespective of the presence or absence of the 
monitoring network. In addition, the fine spatiotemporal resolu-
tion of the exposure enables us to estimate effects on health out-
comes at an individual level over time. The future aim is to extend 
this model across all of India as well as over longer periods of time 
and also for other pollutants, including NO2 and ozone.
Aim 2: Estimate the association between exposure to 
air pollution, temperature, cardiometabolic diseases, 
and risk factors, and identify potential susceptible 
subpopulations
We aim to estimate that the association of ambient air pollution 
exposure from Aim 1 is within the CARRS cohort. In addition to 
estimating main effects, we will evaluate effect modification by 
population subgroups, based on their socioeconomic status, built 
environment, occupational status, and nutritional status to iden-
tify those most susceptible groups. The minimum detectable 
extreme quartile relative risks for 80% power with a 5% Type I 
error rate were calculated for the CARRS-1 cohort in Delhi and 
Chennai (n = 12 271) using the observed 2- and 3-year follow-up 
rates. To assess power of this study to detect correlations in pro-
spective changes in markers of cardiometabolic (CM) risk such as 
HBA1c, lipid profiles, serum creatinine, and blood pressure, we 
find that we will have 80% power to detect correlations as low as 
2% to 3% longitudinally as well as cross-sectionally with baseline 
air pollution (AP) constituents, given the baseline sample size 
and observed follow-up rates at 2 and 3 years.27
Aim 3: Characterize DNA methylation patterns–
associated cardiovascular events and explore whether 
DNA methylation mediates the association between 
air pollution exposure and cardiovascular outcomes
Given the limited sample size and budget, the methylomics 
aim will focus on cardiometabolic outcomes through a nested 
case-control design (approximately n = 192 cardiovascular 
events and controls [myocardial infarction/strokes or CVD 
deaths) to explore whether methylomic patterns mediate the 
effect of PM2.5 exposures on CVD events using mediation 
analyses; 96 cases and controls will provide 98% power to 
detect 5% methylation difference between the groups assuming 
a conservative standard deviation (SD) of 5% in each group at 
P = 1.1 × 10−6.
Aim 4: Explore the association between ambient 
exposure to air pollution and blood vitamin D levels
We will explore associations between air pollution exposure 
and blood vitamin D levels (measured as 25-OH-D levels), 
and we will examine whether vitamin D levels are a mediator 
of the association between air pollution and cardiometabolic 
outcomes using causal mediation analysis. We will randomly 
sample 600 CARRS participants from Delhi and Chennai 
who will provide 80% power or more to detect correlations as 
low as 2% to 3% longitudinally as well as cross-sectionally at 
baseline.
The detailed analysis approach for all the 4 research aims is 
described in Table 3.
Capacity Building
One of the major goals of this study is to build training and 
research capacity to address environmental and occupational 
health research questions beyond the specific aims of this grant. 
We have laid out multiple different ways to achieve this: faculty 
from the Harvard T.H. Chan School of Public Health (HSPH) 
will collaborate and train investigators from Centre for Chronic 
Disease Control (CCDC) and Public Health Foundation of 
India (PHFI):
•• Mentored training program wherein the researchers 
from PHFI and CCDC will work and learn along with 
an identified mentor at HSPH.
•• Summer exchange visits at HSPH, to further strengthen 
capacity of the researchers from PHFI and CCDC.
Table 3. Proposed analysis approach for the research aims.
RESEARCH AIMS ANALySIS APPROACH
Aim 1: Estimation of air pollution exposure A 3-stage hybrid model utilizing machine learning algorithms, 
ensemble averaging, and tensor product smoothing
Aim 2: Estimation of the association between air pollution 
exposure and cardiometabolic disease risk factors and 
diseases
 • Longitudinal mixed effects modeling
 • Time to event modeling for incidence data
Aim 3: Characterization of DNA methylation patterns 
associated cardiovascular health effects and cardiometabolic 
(CM) outcomes
 • Linear regression analyses to identify the DNA methylation profile 
associated with cardiovascular disease (CVD) events
 • Mediation analyses to explore whether these associations are 
mediated by PM2.5 levels
Aim 4: Estimation of the association between air pollution 
exposure and blood vitamin D levels
Mediation analyses to examine the mediating effect of vitamin D in 
association between PM2.5 and cardiovascular disease (CVD)
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•• Master’s training program (fully sponsored MPH or 
MSc in environmental health at HSPH).
•• PHFI and CCDC are running 5-day short courses to 
complement research activities. Courses on introduction 
to environmental health, research ethics in environ-
mental health, air pollution epidemiology, food and the 
environment, principles of toxicology, environmental 
exposure assessment, occupational health and medicine, 
causal modeling, and air pollution, climate, and health: 
modeling and methods have been conducted. The design 
of the courses is such that in the first couple of years, 
HSPH faculty will lead the course and PHFI and CCDC 
faculty can take lead thereafter.
•• HSPH along with faculty from PHFI and CCDC are 
working together in developing curriculum for MPH in 
environmental health track in India.
Innovation
The innovation of our study lies in the methodology of expo-
sure assessment and the estimation of health effects in a cohort 
study with longitudinally measured health outcomes in 2 major 
Indian cities. To date, ambient air pollution exposure assess-
ment in India has been reliant on source apportionment, emis-
sion inventories, satellite remote sensing, and LUR techniques. 
Due to inherent limitations of each methodology, the exposure 
estimates are often coarse in spatial resolution and/or fail to 
capture temporal variability. The methodology used in this 
study incorporates the strengths of multiple machine learning 
techniques along with the most relevant sources of data, thus 
providing high resolution on both spatial and temporal scales. 
To the best of our knowledge, the GEOHealth study is the first 
to assess the effects of ambient air pollution on multiple inci-
dent cardiometabolic disease and associated risk factors in 
India with one of the highest ambient levels of PM2.5 in the 
world. Our results will also help in understanding the complex 
interplay of the role of the air pollution, the built environment, 
occupational exposure, and sociodemographic factors on car-
diometabolic risk factors in India which is facing major devel-
opment and epidemiological transitions.
Air pollution modeling work that will be undertaken in this 
project will improve upon the GBD estimates. This exposure 
assessment approach is much more rigorous and comprehen-
sive, with a fine spatiotemporal resolution of 1 km by 1 km 
compared with GBD resolution of 11 km by 11 km.24 This can 
serve as a resource even for other health outcomes in that 
space-time boundary. In addition, we have individual-level 
information on health and other variables that help in provid-
ing more reliable exposure-response curves.
Impact
Through this GEOHealth Hub, we are enhancing research 
activities and providing scientific infrastructure, training, and 
capacity building to characterize the relationship between air 
pollution and cardiometabolic risk factors and diseases in India. 
This is the largest and most extensive effort to address this 
issue in India, an LMIC with very high air pollution levels and 
prevalence of CM risk factors. The study is expected to pro-
duce results that will (1) advance the science regarding expo-
sure assessment and effects of air pollution on CM risk factors; 
(2) inform urban planning and transportation planning policies 
designed to improve health in India, while taking into account 
air pollution exposures; (3) contribute important information 
to the gap in knowledge on the environmental contributions to 
CM risk factors and how effects are mediated by vitamin D 
levels and epigenetic mechanisms; and (4) inform development 
and implementation of targeted regulations, policies, and inter-
ventions to promote healthier living in India. In addition, this 
research can serve as a template for developing national-level 
pollution models, which can be further used to study the effects 
of pollution on diverse health outcomes.
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